Skip to main content

Table 2 Performance comparison of msInspect, MZmine 2, Progenesis LC-MS, and XCMS.

From: Using a spike-in experiment to evaluate analysis of LC-MS data

msInspect (Number of selected features = 2099, sensitivity = 9/13, FP = 2090)

Feature No.

Peptide

m / z (charge)

q -value (rank)

FC (rank)

1

RGDSPASSKP

501.25 (2)

0.0139 (38)

Inf (1)

2

DRVYIHP

450.23 (2)

0.0114 (1)

Inf (1)

3a

RPPGFSPFR

530.78 (2)

0.0164 (43)

90.5 (1911)

3b

RPPGFSPFR

354.19 (3)

0.0114 (1)

32.5 (1935)

4

DRVYIHPF

523.77 (2)

0.0166 (220)

47.8 (1921)

5a

DRVYIHPFHL

648.84 (2)

0.0120 (28)

Inf (1)

5b

DRVYIHPFHL

432.89 (3)

0.0126 (31)

Inf (1)

6

DRVYIHPFHLLVYS

586.98 (3)

0.0164 (43)

Inf (1)

7a

WLTGPQLADLYHSLMK

624.99 (3)

  

7b

WLTGPQLADLYHSL(M)K

630.35 (3)

0.0164 (43)

Inf (1)

8

YPIVSIEDPFAEDDWEAWSHFFK

943.43 (3)

  

9a

GIGAVLKVLTTGLPALISWIKRKRQQ

712.43 (4)

  

9b

GIGAVLKVLTTGLPALISWIKRKRQQ

570.15 (5)

  

MZmine 2 (Number of selected features = 539, sensitivity = 7/13, FP = 532)

Feature No.

Peptide

m/z (charge)

q-value (rank)

FC (rank)

1

RGDSPASSKP

501.25 (2)

0.0278 (18)

40.0 (243)

2

DRVYIHP

450.23 (2)

0.0271 (1)

97.9 (152)

3a

RPPGFSPFR

530.78 (2)

0.0271 (1)

54.1 (202)

3b

RPPGFSPFR

354.19 (3)

0.0271 (1)

41.4 (238)

4

DRVYIHPF

523.77 (2)

0.0278 (18)

204.9 (107)

5a

DRVYIHPFHL

648.84 (2)

0.0399 (173)

11.2 (509)

5b

DRVYIHPFHL

432.89 (3)

0.0301 (53)

9636.3 (34)

6

DRVYIHPFHLLVYS

586.98 (3)

  

7a

WLTGPQLADLYHSLMK

624.99 (3)

  

7b

WLTGPQLADLYHSL(M)K

630.35 (3)

  

8

YPIVSIEDPFAEDDWEAWSHFFK

943.43 (3)

  

9a

GIGAVLKVLTTGLPALISWIKRKRQQ

712.43 (4)

  

9b

GIGAVLKVLTTGLPALISWIKRKRQQ

570.15 (5)

  

Progenesis LC-MS (Number of selected features = 467, sensitivity = 8/13, FP = 459)

Feature No.

Peptide

m/z (charge)

q-value (rank)

FC (rank)

1

RGDSPASSKP

501.25 (2)

0.0308 (180)

73.0 (178)

2

DRVYIHP

450.23 (2)

0.0103 (1)

33.1 (240)

3a

RPPGFSPFR

530.78 (2)

0.0146 (4)

32.4 (243)

3b

RPPGFSPFR

354.19 (3)

0.0103 (1)

46.9 (210)

4

DRVYIHPF

523.77 (2)

0.0146 (4)

65.8 (184)

5a

DRVYIHPFHL

648.84 (2)

  

5b

DRVYIHPFHL

432.89 (3)

0.0146 (4)

Inf (1)

6

DRVYIHPFHLLVYS

586.98 (3)

  

7a

WLTGPQLADLYHSLMK

624.99 (3)

  

7b

WLTGPQLADLYHSL(M)K

630.35 (3)

0.0222 (33)

50.6 (201)

8

YPIVSIEDPFAEDDWEAWSHFFK

943.43 (3)

  

9a

GIGAVLKVLTTGLPALISWIKRKRQQ

712.43 (4)

  

9b

GIGAVLKVLTTGLPALISWIKRKRQQ

570.15 (5)

0.0441 (365)

Inf (1)

XCMS (Number of selected features = 66, sensitivity = 7/13, FP = 59)

Feature No.

Peptide

m/z (charge)

q-value (rank)

FC (rank)

1

RGDSPASSKP

501.25 (2)

0.0437 (3)

40.0 (8)

2

DRVYIHP

450.23 (2)

0.0224 (1)

25.3 (19)

3a

RPPGFSPFR

530.78 (2)

0.0437 (3)

52.2 (7)

3b

RPPGFSPFR

354.19 (3)

0.0437 (3)

38.0 (9)

4

DRVYIHPF

523.77 (2)

0.0437 (3)

137.8 (2)

5a

DRVYIHPFHL

648.84 (2)

  

5b

DRVYIHPFHL

432.89 (3)

0.0437 (3)

488.4 (1)

6

DRVYIHPFHLLVYS

586.98 (3)

  

7a

WLTGPQLADLYHSLMK

624.99 (3)

  

7b

WLTGPQLADLYHSL(M)K

630.35 (3)

0.0491 (66)

17.9 (27)

8

YPIVSIEDPFAEDDWEAWSHFFK

943.43 (3)

  

9a

GIGAVLKVLTTGLPALISWIKRKRQQ

712.43 (4)

  

9b

GIGAVLKVLTTGLPALISWIKRKRQQ

570.15 (5)

  
  1. The comparison is based on q-value and fold-change (FC) of spike-in peptides in comparing spike-in serum samples versus serum samples. Ranking is provided on q-values and FC. The number of differentially abundant features, sensitivity, and false positives (FP) are calculated based on the criterion of q-value < 0.05 and FC > 10